,:

Zhenqiu Liu1,2, Huangbo Yuan1,2, Chen Suo2,3,4

  • 1State Key Laboratory of Genetic Engineering, Human Phenome Institute, and School of Life Sciences, Fudan University, Shanghai, China.

EClinicalMedicine
|September 12, 2024
PubMed
概括

一个新的风险评分有效地识别了使用常见生物标志物的肝细胞癌 (HCC) 高风险个体. 该工具有助于在一般人群中对HCC风险分层和预测.